Azitra Inc

Research Azitra Inc (AZTR) on Bullrun: market cap USD 2.87M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAZTR
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.87M
• Financial periodFY2025
• Revenue growth-100.0%
• Net income-USD 10.96M
• Free cash flow-USD 11.25M

Valuation Snapshot

latest market cap is USD 2.87M.

About Azitra Inc

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S.

Frequently asked questions

What is Azitra Inc's market cap?

Azitra Inc's market capitalization is USD 2.87M.

What does Azitra Inc do?

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.